Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Novartis image

Two Novartis drugs get first in class EU approvals

September 2, 2015
Research and Development, Sales and Marketing Novartis

The European Commission has approved Revolade for severe aplastic anaemia, and the combination of Tafinlar and Mekinist for patients with …

News
novartis

Novartis buys rights to GSK MS drug for up to $1 billion

August 21, 2015
Medical Communications, Research and Development, Sales and Marketing GlaxoSmithKline, Novartis, multiple sclerosis, ofatumumab

Novartis has added to its burgeoning multiple sclerosis portfolio with the $300 million acquisition of all outstanding rights to GlaxoSmithKline’s …

News
Advanced melanoma

Novartis and Merck skin cancer drugs move through pipeline

August 20, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Merck, Novartis, Odomzo, basal cell carcinoma, keytruda, melanoma, pembrolizumab, skin cancer, sonidegib

Both Novartis and Merck have hit regulatory milestones with their skin cancer drugs in the EU and the US. Novartis’ …

News
Code of Practice

Bayer’s complaint over ‘misleading’ Novartis eye drug claims upheld

August 14, 2015
Medical Communications Bayer, Eylea, Lucentis, Novartis, PMCPA, code of conduct

The industry’s code of conduct regulator has ruled in favour of Bayer in a dispute claims made by Novartis when …

News

CSL completes $275m Novartis vaccines acquisition

August 3, 2015
Manufacturing and Production, Sales and Marketing CSL, Novartis, acquisitions, asset swap, vaccines

CSL Limited has finalised its transaction to acquire Novartis’s global influenza vaccine business for $275 million. The move means Novartis …

News
Novartis window

Novartis forms Mereo as UK biotech spin-off

July 29, 2015
Research and Development Mereo, Novartis, biotech, rare diseases

Novartis has formed a new UK biotech company by selling three investigational drugs in exchange for shares in the new …

News
dr_joerg_reinhardt

Novartis Foundation confirms Dr Joerg Reinhard as new chairman

July 27, 2015
Manufacturing and Production, Medical Communications Dr Joerg Reinhardt, Novartis

The Novartis Foundation has confirmed several new members of its board of trustees, including a new chairman in Dr Joerg …

Appointment
Novartis image

FDA approves Novartis drug Odomzo

July 27, 2015
Sales and Marketing Novartis, Odomzo, basal cell carcinoma, skin cancer

The FDA has given the Swiss firm the go-ahead to market its drug for skin cancer. Odomzo (sonidegib, formerly LDE225) …

News
Novartis

Sandoz and pharma division boost Novartis sales

July 21, 2015
Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales

Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …

News

Novartis and Pfizer to close factories in India

July 21, 2015
Manufacturing and Production India, Novartis, Pfizer, Sandoz, manufacturing

Two big pharma firms have announced they will close manufacturing facilities in India as they seek to restructures their global …

News
WHO flag

Novartis receives WHO nod for malaria drug Coartem

July 17, 2015
Manufacturing and Production Coartem, Novartis, WHO, antimalarial, malaria, world health organization

The World Health Organization will add Novartis’ antimalarial treatment Coartem to the prequalified list of vaccines that is supplies to …

News
Novartis image

Novartis wins US nod for new heart drug

July 8, 2015
Research and Development, Sales and Marketing Entestro, FDA, LCZ696, Novartis, ejection fraction, heart failure, reduced ejection fraction, sacubitril

The FDA has given the green light to Novartis’ new heart failure drug, six weeks ahead of the scheduled date …

News

Novartis launches ViaOpta Apple Watch app

July 1, 2015
Medical Communications Novartis, apple watch, apps, visual impairment, wearables

Novartis has launched new features of its ViaOpta app for use with the Apple Watch and other wearable devices. The …

News

Novartis spends $200m on pain firm Spinifex

June 29, 2015
Sales and Marketing Cosentyx, EMA401, Novartis, Secukinumab, spinifex

Novartis is spending $200 million to increase its presence in pain management through the purchase of US-Australian biotech Spinifex Pharmaceuticals.  …

News
EMA image

EMA waves through a raft of drug recommendations

June 26, 2015
Research and Development, Sales and Marketing AbbVie, Alexion, CHMP, EMA, Novartis, Novo Nordisk, brett wells

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended several treatments for marketing …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025